Thoracic Cancer

Radiotherapy highlights at TTLC 2022 1:06
Radiotherapy highlights at TTLC 2022
Charles Simone • 28 Feb 2022
Optimizing CAR T-cell therapies for thoracic cancers 1:28
Optimizing CAR T-cell therapies for thoracic cancers
Prasad Adusumilli • 8 Mar 2022
The role of radiotherapy in mesothelioma and thymic carcinoma 1:29
The role of radiotherapy in mesothelioma and thymic carcinoma
Charles Simone • 28 Feb 2022
Proton therapy in thoracic cancer and mesothelioma 1:27
Proton therapy in thoracic cancer and mesothelioma
Charles Simone • 28 Feb 2022
Nintedanib plus steroid taper in radiation pneumonitis 3:11
Nintedanib plus steroid taper in radiation pneumonitis
Zachary Moore • 14 Sep 2021
Impact of autoimmune disease co-occurring with thymic epithelial tumors and Good’s syndrome 3:09
Impact of autoimmune disease co-occurring with thymic epithelial tumors and Good’s syndrome
Margaret Ottaviano • 2 Feb 2021
ccfDNA to monitor the biological course of thymic epithelial tumors 3:43
ccfDNA to monitor the biological course of thymic epithelial tumors
Margaret Ottaviano • 2 Feb 2021
Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results 2:28
Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results
Yannis Metaxas • 29 Sep 2019
Tackling urgent questions in EGFRm NSCLC 2:44
Tackling urgent questions in EGFRm NSCLC
Nicolas Girard • 8 Sep 2017
Toxicity: immunotherapy vs chemotherapy 2:09
Toxicity: immunotherapy vs chemotherapy
Benjamin Besse • 8 Sep 2017
Exciting results from the ALEX trial 2:23
Exciting results from the ALEX trial
Silvia Novello • 8 Sep 2017
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals